מדינה: הממלכה המאוחדת
שפה: אנגלית
מקור: MHRA (Medicines & Healthcare Products Regulatory Agency)
Vitamin A; Ergocalciferol; Ascorbic acid; Thiamine nitrate; Riboflavin; Pyridoxine hydrochloride; Nicotinamide; Calcium pantothenate; Alpha tocopheryl acetate
Wallace Manufacturing Chemists Ltd
Vitamin A; Ergocalciferol; Ascorbic acid; Thiamine nitrate; Riboflavin; Pyridoxine hydrochloride; Nicotinamide; Calcium pantothenate; Alpha tocopheryl acetate
5000unit ; 500unit ; 40mg ; 2.5mg ; 2.5mg ; 1mg ; 20mg ; 5mg ; 2unit
Oral capsule
Oral
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: 09100000; GTIN: 05034593044603 05034593043606
Concavit Capsules Concavit Capsules Each Capsule contains: - Vitamin A BP 5000.00 iu Calciferol BP 500.00 iu Ascorbic Acid BP 40.00 mg Thiamine Mononitrate BP 2.50 mg Riboflavine BP 2.50 mg Pyridoxine Hydrochloride BP 1.00 mg Nicotinamide BP 20.00 mg Calcium Pantothenate BP 5.00 mg dl- -Tocopheryl Acetate BP 2.00 iu In addition the capsules also contain: Soya Bean Oil, Fat mixture, Soya Lecithin, Gelatin, Glycerin, Sorbitol, Hydroxybenzoates (Ethyl and Propyl), Ponceau 4R (E124) and water. Concavit capsules are available in packs of 25 and 100. Concavit is an oral vitamin supplement. The product licence holder is Wallace Manufacturing Chemists Ltd., Wallace House, 51-53 Stert Street, Abingdon, Oxfordshire OX14 3JF, United Kingdom and the capsules are manufactured by Catalent UK Swindon Encaps Limited, Frankland Road, Blagrove Estate, Swindon, Wiltshire SN5 8YG, England. Product Licence No: PL 00400/5009R Concavit is intended as a multiple vitamin supplement in situations of special dietary need. It is not intended for the correction of specific vitamin deficiencies. BEFORE YOU USE CONCAVIT Do not use Concavit to treat vitamin deficiencies caused by inability to absorb the vitamin(s) orally. Do not use Concavit if: You are hypersensitive to any of the ingredients You have a history of high levels of Vitamins A or D You have bone tumours You have elevated blood calcium levels. You have abnormal metabolic sensitivity to vitamin D Do not take Vitamin A supplements if you are pregnant or likely to become pregnant except on the advice of your doctor or antenatal clinic. PRECAUTIONS FOR THE USE OF CONCAVIT Do not exceed the stated dose. INTERACTIONS WITH OTHER MEDICINE Concavit may react with other medicines you are taking. Concavit contains a range of Vitamins and each can affect and in turn be affected by other medicines you are taking. Consult with your doctor or pharmacist if you are taking other medicines. The following medicines will alter the absorption of one or more ingredients in Concav קרא את המסמך השלם
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Concavit Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each Capsule contains: - Vitamin A BP 5000.00 iu Calciferol BP 500.00 iu Ascorbic Acid BP 40.00 mg Thiamine Mononitrate BP 2.50 mg Riboflavine BP 2.50 mg Pyridoxine Hydrochloride BP 1.00 mg Nicotinamide BP 20.00 mg Calcium Pantothenate BP 5.00 mg dl- α -Tocopheryl Acetate BP 2.00 iu 3. PHARMACEUTICAL FORM Soft Gelatine Capsules 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a supplement of multiple vitamins in situations of special dietary need. Not suitable for the correction of specific vitamin deficiencies. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults, The Elderly and Children - 1 capsule daily 4.3 CONTRAINDICATIONS • Oral administration in the treatment of deficiency state in malabsorption syndromes. • Hypersensitivity to any of the ingredients. • History of hypervitaminoses A or D. • Sarcoidosis • Hypercalcaemia • Abnormal metabolic sensitivity to Vitamin D. • Do not take Vitamin A supplements if you are pregnant or likely to become pregnant except on the advice of a doctor or antenatal clinic. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE There are serious risks of developing hypercalcaemia when calcium salts or thiazides are co-administered. Serum calcium, phosphate, alkaline phosphatase, liver function tests and magnesium should be monitored when indicated. Absorption of Vitamin A is reduced in cystic fibrosis, hepatic diseases, pancreatic dysfunction and in patients with intestinal infections. The use of Vitamin A in renal diseases requires extreme caution. 4.5 INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION • Contraceptive pills raise plasma levels of Vitamin A. • Agents such as bile acid resins, e.g. cholestyramine and colestipol impair the absorption of fats including the Vitamins A and D. • As both Vitamin D and thiazide diuretics increase the plasma concentration of calcium, co-administration of these agents may res קרא את המסמך השלם